IOSP
Innospec Inc.
Chemicals - Specialty
Market Cap$1.91B
5Y Perf.-0.6%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
IOSP vs HWKN vs BCPC vs KWR vs AVNT
Revenue, margins, valuation, and 5-year total return — side by side.
HWKN
Hawkins, Inc.
Chemicals - Specialty
Market Cap$3.46B
5Y Perf.+678.6%
BCPC
Balchem Corporation
Chemicals - Specialty
Market Cap$5.11B
5Y Perf.+58.5%
KWR
Quaker Chemical Corporation
Chemicals - Specialty
Market Cap$2.48B
5Y Perf.-16.3%
AVNT
Avient Corporation
Chemicals - Specialty
Market Cap$3.35B
5Y Perf.+47.3%
IOSP vs HWKN vs BCPC vs KWR vs AVNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | IOSP | HWKN | BCPC | KWR | AVNT |
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $1.91B | $3.46B | $5.11B | $2.48B | $3.35B |
| Revenue (TTM) | $1.78B | $1.06B | $1.06B | $1.93B | $3.28B |
| Net Income (TTM) | $117M | $82M | $158M | $4M | $158M |
| Gross Margin | 27.7% | 22.9% | 36.3% | 34.4% | 31.7% |
| Operating Margin | 8.7% | 11.5% | 21.0% | 3.7% | 9.3% |
| Forward P/E | 15.5x | 42.3x | 30.9x | 19.3x | 12.0x |
| Total Debt | $90M | $160M | $192M | $929M | $1.92B |
| Cash & Equiv. | $293M | $5M | $75M | $180M | $511M |
IOSP vs HWKN vs BCPC vs KWR vs AVNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
IOSP
HWKN
BCPC
KWR
AVNT
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
| Hawkins, Inc. (HWKN) | 100 | 778.6 | +678.6% |
| Balchem Corporation (BCPC) | 100 | 158.5 | +58.5% |
| Quaker Chemical Cor… (KWR) | 100 | 83.7 | -16.3% |
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IOSP vs HWKN vs BCPC vs KWR vs AVNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: BCPC leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Avient Corporation is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. KWR also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
IOSP
Innospec Inc.
The Defensive Pick
IOSP is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.70, Low D/E 6.7%, current ratio 2.79x
- PEG 0.48 vs BCPC's 2.41
- Beta 0.70, yield 2.2%, current ratio 2.79x
Best for: sleep-well-at-night and valuation efficiency
HWKN
Hawkins, Inc.
The Long-Run Compounder
HWKN is the clearest fit if your priority is long-term compounding.
- 7.7% 10Y total return vs BCPC's 160.5%
Best for: long-term compounding
BCPC
Balchem Corporation
The Growth Play
BCPC carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- 8.8% revenue growth vs IOSP's -3.7%
- 15.0% margin vs KWR's 0.2%
- Beta 0.33 vs KWR's 1.35, lower leverage
Best for: growth exposure
KWR
Quaker Chemical Corporation
The Momentum Pick
KWR ranks third and is worth considering specifically for momentum.
- +45.1% vs IOSP's -14.9%
Best for: momentum
AVNT
Avient Corporation
The Income Pick
AVNT is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
- Lower P/E (12.0x vs 19.3x)
- 2.9% yield, 14-year raise streak, vs BCPC's 0.5%
Best for: income & stability
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | BCPC | 8.8% revenue growth vs IOSP's -3.7% |
| Value | AVNT | Lower P/E (12.0x vs 19.3x) |
| Quality / Margins | BCPC | 15.0% margin vs KWR's 0.2% |
| Stability / Safety | BCPC | Beta 0.33 vs KWR's 1.35, lower leverage |
| Dividends | AVNT | 2.9% yield, 14-year raise streak, vs BCPC's 0.5% |
| Momentum (1Y) | KWR | +45.1% vs IOSP's -14.9% |
| Efficiency (ROA) | BCPC | 9.4% ROA vs KWR's 0.2%, ROIC 12.2% vs 6.6% |
IOSP vs HWKN vs BCPC vs KWR vs AVNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
IOSP vs HWKN vs BCPC vs KWR vs AVNT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLAVNTLAGGINGKWR
Who Leads Where
AVNT leads in 2 of 6 categories
BCPC leads 1 • HWKN leads 1 • IOSP leads 0 • KWR leads 0 • 2 tied
Explore the data ↓KWRQuaker Chemical Corpo…
0leads
IOSPInnospec Inc.
0leads
BCPCBalchem Corporation
1leads
HWKNHawkins, Inc.
1leads
AVNTAvient Corporation
2leads
6 Total Categories
CATEGORYLEADERvs HWKNvs BCPCMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
BCPC4/6
Valuation MetricsMultiples, price ratios, and targets
AVNT4/7
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
HWKN4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
AVNT2/2
Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVNT is the larger business by revenue, generating $3.3B annually — 3.1x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to KWR's 0.2%. On growth, KWR holds the edge at +8.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | IOSPInnospec Inc. | HWKNHawkins, Inc. | BCPCBalchem Corporati… | KWRQuaker Chemical C… | AVNTAvient Corporation |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $1.1B | $1.1B | $1.9B | $3.3B |
| EBITDAEarnings before interest/tax | $198M | $172M | $267M | $143M | $445M |
| Net IncomeAfter-tax profit | $117M | $82M | $158M | $4M | $158M |
| Free Cash FlowCash after capex | $88M | $88M | $182M | $143M | $205M |
| Gross MarginGross profit ÷ Revenue | +27.7% | +22.9% | +36.3% | +34.4% | +31.7% |
| Operating MarginEBIT ÷ Revenue | +8.7% | +11.5% | +21.0% | +3.7% | +9.3% |
| Net MarginNet income ÷ Revenue | +6.6% | +7.8% | +15.0% | +0.2% | +4.8% |
| FCF MarginFCF ÷ Revenue | +4.9% | +8.2% | +17.2% | +7.4% | +6.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | +7.9% | +8.1% | +8.5% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +167.7% | -4.2% | +10.6% | +54.8% | +3.8% |
BCPC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
AVNT leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 16.4x trailing earnings, IOSP trades at a 60% valuation discount to HWKN's 41.4x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs BCPC's 2.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | IOSPInnospec Inc. | HWKNHawkins, Inc. | BCPCBalchem Corporati… | KWRQuaker Chemical C… | AVNTAvient Corporation |
|---|---|---|---|---|---|
| Market CapShares × price | $1.9B | $3.5B | $5.1B | $2.5B | $3.3B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $3.6B | $5.2B | $3.2B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | 16.41x | 41.44x | 33.58x | -1021.00x | 41.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.45x | 42.31x | 30.87x | 19.32x | 11.95x |
| PEG RatioP/E ÷ EPS growth rate | 0.51x | 1.67x | 2.62x | — | — |
| EV / EBITDAEnterprise value multiple | 8.29x | 22.74x | 19.83x | 11.93x | 12.22x |
| Price / SalesMarket cap ÷ Revenue | 1.07x | 3.55x | 4.92x | 1.31x | 1.03x |
| Price / BookPrice ÷ Book value/share | 1.44x | 7.60x | 4.14x | 1.81x | 1.40x |
| Price / FCFMarket cap ÷ FCF | 21.68x | 49.48x | 29.51x | 30.74x | 17.16x |
AVNT leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
Evenly matched — IOSP and HWKN and BCPC each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
HWKN delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $0 for KWR. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVNT's 0.81x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs KWR's 4/9, reflecting strong financial health.
| Metric | IOSPInnospec Inc. | HWKNHawkins, Inc. | BCPCBalchem Corporati… | KWRQuaker Chemical C… | AVNTAvient Corporation |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.0% | +15.9% | +12.4% | +0.3% | +6.6% |
| ROA (TTM)Return on assets | +6.5% | +8.4% | +9.4% | +0.2% | +2.6% |
| ROICReturn on invested capital | +11.2% | +15.9% | +12.2% | +6.6% | +3.9% |
| ROCEReturn on capital employed | +11.0% | +19.3% | +14.8% | +7.6% | +4.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 9 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.07x | 0.35x | 0.15x | 0.67x | 0.81x |
| Net DebtTotal debt minus cash | -$203M | $155M | $117M | $749M | $1.4B |
| Cash & Equiv.Liquid assets | $293M | $5M | $75M | $180M | $511M |
| Total DebtShort + long-term debt | $90M | $160M | $192M | $929M | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 10.27x | 15.23x | 1.41x | 3.61x |
Evenly matched — IOSP and HWKN and BCPC each lead in 3 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
HWKN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HWKN five years ago would be worth $49,115 today (wi